Gulf News

المملكة: Adopting targeted treatments and personalized medicine…the most prominent recommendations of the Al-Ahsa Oncology Conference


Scientific discussions at the Al-Ahsa Oncology Conference produced fundamental recommendations that called for an immediate change in therapeutic protocols, and the adoption of “targeted therapies” in the first lines of treatment, based on controlled and updated studies that proved their maximum effectiveness.

The scientific outcomes of the conference confirmed that modern health practice requires the use of these Advanced Actions; Due to the tangible positive outcomes you have demonstrated that raise the quality of care provided to oncology patients and increase the chances of recovery.

This came during the inauguration of the conference activities by the Undersecretary of Al-Ahsa Governorate, Moaz Al-Jaafari, on Friday, under the patronage of His Royal Highness Prince Saud bin Talal bin Badr, Governor of Al-Ahsa, and organized by the Al-Ahsa Health Cluster at the Al-Ahsa Intercontinental Hotel.

The Governor’s support for the health sector

The Undersecretary of the Governorate stressed in his speech Editorial that takes care of His Highness the Governor This event embodies his great concern and continuous interest in the health of citizens, and his constant directive to improve the quality of health services and support initiatives that promote prevention and early diagnosis.

Al-Jaafari explained that His Highness’s continued support for the health sector clearly reflects the vision of the wise leadership in providing the best services to the community, and enhances the efforts of medical personnel to provide distinguished health care, praising the great efforts of the Al-Ahsa Health Assembly in organizing this qualitative event.

For his part, the President said Executive Director of Al-Ahsa Health Cluster, Dr. Khaled Al-Mulla: “Thank you for being here today to cover the conference. The truth is that the conference comes with the generous support and care of His Royal Highness, Governor of Al-Ahsa, Prince Saud bin Talal bin Badr.”

Al-Mulla added: "The conference comes to embody the integration between all The medical and health sectors operating in Al-Ahsa that treat oncology diseases, and also with the support of associations specialized in this field, and the support of our partners from the companies sponsoring the conference."

The most prominent numbers and topics

The CEO reviewed the numbers and topics, saying: “The conference contains more than 16 educational hours of continuing education, and more than 45 speakers and participants from inside and outside the Kingdom, embodying all journeys of oncology treatment, from preventive treatment and early detection, to treatment if the case requires various treatments, whether hormonal, radiation, or other, and also the rehabilitation stage.”

Al-Mulla concluded his speech by focusing on the human staff: “With God’s will, we are keen during this and other conferences to intensify efforts to develop the human cadre who cares for oncology services, to reach the latest scientific methods, what scientific studies have proven, and the latest evidence in treating oncology, to reach the highest service to the beneficiaries, God willing.”

For his part, the head of the conference’s organizing committee, Dr. Abdul Rahman Al-Abd Al-Aali, detailed the radical transformation in treatment methods, saying: “The conference is held by an elite group of specialists and those interested in this field, with more than forty speakers. And an interviewer and moderator of sessions for scientific discussions aimed at raising the level of care and quality for oncology patients, may God heal them all.”

Practical development in the quality of health care

Al-Abdulali pointed to the essence of the new scientific development: “We discuss the most prominent findings of science in terms of recent studies and scientific developments of targeted therapy and immunotherapy, and personalized medicine that puts the patient at the heart of the treatment decision, not as a general characteristic, but rather as having its own unique biological characteristics.”

He stressed the responsibility of keeping up with this development: “This is what happened and what has been done in this science, and we are keeping pace and we have a great responsibility to keep pace with this scientific development to raise the level and quality of care, and this is what the Al-Ahsa Health Cluster with all its components seeks, in light of the great support we have in the health sector in our dear country.”

In detailing the precise scientific recommendations, Dr. Al-Abd Al-Ali said: “Among the most prominent of the recommendations made today, through the first lectures, are some studies that talk about targeted treatments in therapeutic lines.” The first; These are peer-reviewed and updated studies, and now health practice calls for the use of these procedures when they demonstrate positive outcomes in the quality of care for oncology patients.”

He added, explaining the readiness of the local centers: “These practices, and praise be to God, we keep up with on an ongoing basis at the Hamad Al-Jabr Oncology Center, and oncology centers in general in our beloved Kingdom, to keep pace with everything that would raise the level of care, and to reach the hope of recovery, God willing, for oncology patients.”

A warm welcome. The guests

Al-Abdulali welcomed the guests with a human touch, saying: “To our esteemed guests from outside Al-Ahsa, we welcome them with the warmest welcome in this oasis rich in its heritage. God willing, after the conference, there will be a tour of the most prominent landmarks of Al-Ahsa for our esteemed guests. We are happy with your presence and thank you to everyone who contributed to organizing this conference.”

The ceremony concluded with the governor’s representative honoring the organizing and scientific committee and the sponsors, and reviewing the accompanying pillars, to begin. Then, two days of intensive scientific sessions will be held to discuss the latest clinical developments and highlight evidence-based practices.

Related Articles

Back to top button